SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-398772
Filing Date
2014-11-05
Accepted
2014-11-05 17:15:25
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d791029d10q.htm 10-Q 605160
2 EX-10.2 d791029dex102.htm EX-10.2 678280
3 EX-31.1 d791029dex311.htm EX-31.1 8242
4 EX-31.2 d791029dex312.htm EX-31.2 8274
5 EX-32.1 d791029dex321.htm EX-32.1 4835
12 GRAPHIC g791029graphic_1.jpg GRAPHIC 5434
  Complete submission text file 0001193125-14-398772.txt   5726143

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgnt-20140930.xml EX-101.INS 656278
7 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20140930.xsd EX-101.SCH 48793
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20140930_cal.xml EX-101.CAL 78907
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20140930_def.xml EX-101.DEF 317290
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20140930_lab.xml EX-101.LAB 390374
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20140930_pre.xml EX-101.PRE 374421
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35144 | Film No.: 141197777
SIC: 2834 Pharmaceutical Preparations